Washington Examiner - Political News and Conservative Analysis About Congress, the President, and the Federal Government
AÂ clinical trial has demonstrated adults with peanut allergies may be able to eat small doses if they undergo fecal transplants, a hospital announced Saturday.
Fecal microbiota transplanted out of nonallergic donors into allergic people who previously could only eat less than half a peanut before reacting resulted in adults who became resilient to two peanuts, Boston Children’s Hospital said.
“These results were very encouraging,” said Dr. Rima Rachid, the lead investigator and co-director of the Food Allergy Program at the hospital. “A single FMT led to a significant increase in the threshold of reactivity to peanut at both 1 month and 4 months after treatment, showing that the effect was prolonged. This study is offering hope that microbiome interventions may be effective in food allergy.”
